# TD-9855 Mass Balance Study

> **NCT01924143** · PHASE1 · COMPLETED · sponsor: **Theravance Biopharma** · enrollment: 6 (actual)

## Conditions studied

- ADHD
- Fibromyalgia

## Interventions

- **DRUG:** TD-9855

## Key facts

- **NCT ID:** NCT01924143
- **Lead sponsor:** Theravance Biopharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2013-11
- **Final completion:** 2013-12
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2021-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01924143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01924143, "TD-9855 Mass Balance Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01924143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*